PFIZER Malaysia today launched two new treatments for haemophiliac patients in Malaysia, indicated for the treatment of haemophilia A and B.
Xyntha Antihemophilic Factor (Recombinant) Plasma/Albumin-Free, is an injectable medicine for both the control and prevention of bleeding episodes and surgical prophylaxis in patients with hemophilia A.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!